CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-01 | Kieffer Tara Lynn Sr. VP, New Product Dev. | Shares withheld for taxes | −498 | $44.33 | $22K | 25,866 |
| 2022-12-01 | Gardiner Nathaniel S. Sr. VP & General Counsel | Shares withheld for taxes | −1,055 | $44.33 | $47K | 59,051 |
| 2022-12-01 | Or Yat Sun Sr. VP & CSO | Shares withheld for taxes | −1,055 | $44.33 | $47K | 359,187 |
| 2022-12-01 | MELLETT PAUL J Treasurer and CFO | Shares withheld for taxes | −1,055 | $44.33 | $47K | 81,503 |
| 2022-12-01 | Luly Jay R. President and CEO | Shares withheld for taxes | −5,659 | $44.33 | $251K | 773,805 |
| 2022-11-23 | Luu Brendan Sr. VP, Business Dev. | Grant or award | +18,500 | 26,223 | ||
| 2022-11-23 | Luu Brendan Sr. VP, Business Dev. | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-11-23 | Kieffer Tara Lynn Sr. VP, New Product Dev. | Grant or award | +18,500 | 26,364 | ||
| 2022-11-23 | Kieffer Tara Lynn Sr. VP, New Product Dev. | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-11-23 | Gardiner Nathaniel S. Sr. VP & General Counsel | Grant or award | +21,000 | 60,106 | ||
| 2022-11-23 | Gardiner Nathaniel S. Sr. VP & General Counsel | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2022-11-23 | Rottinghaus Scott T. Chief Medical Officer | Grant or award | +7,000 | 27,000 | ||
| 2022-11-23 | Rottinghaus Scott T. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-11-23 | Or Yat Sun Sr. VP & CSO | Grant or award | +21,000 | 360,242 | ||
| 2022-11-23 | Or Yat Sun Sr. VP & CSO | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2022-11-23 | MELLETT PAUL J Treasurer and CFO | Grant or award | +21,000 | 82,558 | ||
| 2022-11-23 | MELLETT PAUL J Treasurer and CFO | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2022-11-23 | Luly Jay R. President and CEO | Grant or award | +63,000 | 779,464 | ||
| 2022-11-23 | Luly Jay R. President and CEO | Grant or award · Stock Option (right to buy) | +134,000 | 134,000 | ||
| 2022-08-08 | Rottinghaus Scott T. Chief Medical Officer | Grant or award | +20,000 | 20,000 |
Page 11 of 19 · 377 trades